CORZ
Core Scientific, Inc.
17.30$
-4.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 86.3% | 72.3% | 56.7% | 72.5% | 100.2% | 95.0% | 89.7% | 93.6% | 95.3% | 74.0% | 74.2% | 57.3% | 71.8% | |
| 13.7% | 27.7% | 43.3% | 27.5% | -0.2% | 5.0% | 10.3% | 6.4% | 4.7% | 26.2% | 25.8% | 42.7% | 28.3% | |
| 2.0% | 1.3% | 1.0% | 1.5% | 3.0% | 5.3% | – | – | – | – | – | – | – | |
| 20.8% | 17.1% | 9.4% | 18.6% | 36.0% | 37.6% | 56.0% | 72.4% | 85.5% | 20.3% | 39.2% | 30.1% | 40.9% | |
| 24.3% | 24.9% | 12.5% | 22.8% | 43.1% | 46.9% | 69.5% | 39.8% | 85.4% | 9.9% | 46.4% | 86.6% | 61.9% | |
| -10.7% | 2.8% | 30.8% | 4.7% | -43.2% | -41.9% | -59.1% | -33.4% | -80.7% | 16.3% | -20.6% | -43.9% | -33.7% | |
| 1.9% | 59.1% | 7.9% | 10.5% | 7.4% | 1.2% | 2.8% | 1.5% | 1.0% | 1.1% | 4.2% | 14.5% | 6.9% | |
| -36.3% | -137.6% | 117.6% | -570.3% | -477.3% | -279.3% | 724.9% | -1,191.2% | -180.7% | 268.6% | -300.7% | -702.4% | -325.3% | |
| 0.1% | 0.2% | 0.1% | 0.1% | 0.1% | 0.4% | 0.3% | 0.2% | 0.2% | 0.1% | 0.5% | 1.2% | 0.6% | |
| -36.4% | -137.9% | 117.5% | -570.4% | -477.4% | -279.7% | 724.6% | -1,191.4% | -180.8% | 268.5% | -301.3% | -703.6% | -325.9% | |
| -12.7% | -56.7% | 142.1% | 27.1% | -438.7% | -247.4% | 753.0% | -0.8% | -157.2% | 277.1% | -279.3% | -678.5% | -304.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.